| Product Code: ETC071128 | Publication Date: Jun 2021 | Updated Date: Aug 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Infectious Disease Biomarker Testing Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Infectious Disease Biomarker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Infectious Disease Biomarker Testing Market - Industry Life Cycle |
3.4 United Kingdom (UK) Infectious Disease Biomarker Testing Market - Porter's Five Forces |
3.5 United Kingdom (UK) Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.6 United Kingdom (UK) Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 United Kingdom (UK) Infectious Disease Biomarker Testing Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 United Kingdom (UK) Infectious Disease Biomarker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in the UK |
4.2.2 Growing awareness about the importance of early disease detection and personalized medicine |
4.2.3 Technological advancements in biomarker testing leading to more accurate and rapid diagnosis |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for biomarker testing products |
4.3.2 Limited reimbursement policies for biomarker testing services in the UK |
5 United Kingdom (UK) Infectious Disease Biomarker Testing Market Trends |
6 United Kingdom (UK) Infectious Disease Biomarker Testing Market, By Types |
6.1 United Kingdom (UK) Infectious Disease Biomarker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Infectious Disease Biomarker Testing Market Revenues & Volume, By Product, 2018 - 2027F |
6.1.3 United Kingdom (UK) Infectious Disease Biomarker Testing Market Revenues & Volume, By Assays, Kits and Reagents, 2018 - 2027F |
6.1.4 United Kingdom (UK) Infectious Disease Biomarker Testing Market Revenues & Volume, By Instruments, 2018 - 2027F |
6.1.5 United Kingdom (UK) Infectious Disease Biomarker Testing Market Revenues & Volume, By Services and Software, 2018 - 2027F |
6.2 United Kingdom (UK) Infectious Disease Biomarker Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Infectious Disease Biomarker Testing Market Revenues & Volume, By Immunodiagnostics, 2018 - 2027F |
6.2.3 United Kingdom (UK) Infectious Disease Biomarker Testing Market Revenues & Volume, By Clinical Microbiology, 2018 - 2027F |
6.2.4 United Kingdom (UK) Infectious Disease Biomarker Testing Market Revenues & Volume, By PCR, 2018 - 2027F |
6.2.5 United Kingdom (UK) Infectious Disease Biomarker Testing Market Revenues & Volume, By INAAT, 2018 - 2027F |
6.2.6 United Kingdom (UK) Infectious Disease Biomarker Testing Market Revenues & Volume, By DNA Sequencing and NGS, 2018 - 2027F |
6.2.7 United Kingdom (UK) Infectious Disease Biomarker Testing Market Revenues & Volume, By Other Technologies, 2018 - 2027F |
6.3 United Kingdom (UK) Infectious Disease Biomarker Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Infectious Disease Biomarker Testing Market Revenues & Volume, By Physician Offices, 2018 - 2027F |
6.3.3 United Kingdom (UK) Infectious Disease Biomarker Testing Market Revenues & Volume, By Reference Laboratories, 2018 - 2027F |
6.3.4 United Kingdom (UK) Infectious Disease Biomarker Testing Market Revenues & Volume, By Hospitals, 2018 - 2027F |
6.3.5 United Kingdom (UK) Infectious Disease Biomarker Testing Market Revenues & Volume, By Academic and Research Institutes, 2018 - 2027F |
6.3.6 United Kingdom (UK) Infectious Disease Biomarker Testing Market Revenues & Volume, By Others, 2018 - 2027F |
7 United Kingdom (UK) Infectious Disease Biomarker Testing Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Infectious Disease Biomarker Testing Market Export to Major Countries |
7.2 United Kingdom (UK) Infectious Disease Biomarker Testing Market Imports from Major Countries |
8 United Kingdom (UK) Infectious Disease Biomarker Testing Market Key Performance Indicators |
8.1 Adoption rate of biomarker testing technologies in healthcare facilities |
8.2 Number of research studies and clinical trials utilizing infectious disease biomarker testing |
8.3 Investment trends in biomarker testing companies in the UK |
9 United Kingdom (UK) Infectious Disease Biomarker Testing Market - Opportunity Assessment |
9.1 United Kingdom (UK) Infectious Disease Biomarker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United Kingdom (UK) Infectious Disease Biomarker Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 United Kingdom (UK) Infectious Disease Biomarker Testing Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 United Kingdom (UK) Infectious Disease Biomarker Testing Market - Competitive Landscape |
10.1 United Kingdom (UK) Infectious Disease Biomarker Testing Market Revenue Share, By Companies, 2021 |
10.2 United Kingdom (UK) Infectious Disease Biomarker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here